Association between FTO gene polymorphism and cancer risk: evidence from 16,277 cases and 31,153 controls (original) (raw)

References

  1. Wang D, Zheng W, Wang SM, Wang JB, Wei WQ, Liang H, et al. Estimation of cancer incidence and mortality attributable to overweight, obesity, and physical inactivity in China. Nutr Cancer. 2012;64:48–56.
    Article Google Scholar
  2. Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM, et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science. 2007;316:889–94.
    Article CAS Google Scholar
  3. Xi B. Mi J.FTO polymorphisms are associated with obesity but not with diabetes in East Asian populations: a meta-analysis. Biomed Environ Sci. 2009;22:449–57.
    Article CAS Google Scholar
  4. Adeyemo A, Chen G, Zhou J, Shriner D, Doumatey A, Huang H, et al. FTO genetic variation and association with obesity in West Africans and African Americans. Diabetes. 2010;59:1549–54.
    Article CAS Google Scholar
  5. Wang H, Dong S, Xu H, Qian J, Yang J. Genetic variants in FTO associated with metabolic syndrome: a meta- and gene-based analysis. Mol Biol Rep. 2011. doi:10.1007/s11033-011-1377-y.
  6. Cecil JE, Tavendale R, Watt P, Hetherington MM, Palmer CN. An obesity-associated FTO gene variant and increased energy intake in children. N Engl J Med. 2008;359:2558–66.
    Article CAS Google Scholar
  7. Kaklamani V, Yi N, Sadim M, Siziopikou K, Zhang K, Xu Y, et al. The role of the fat mass and obesity associated gene (FTO) in breast cancer risk. BMC Med Genet. 2011;12:52.
    Article CAS Google Scholar
  8. Kusinska R, Górniak P, Pastorczak A, Fendler W, Potemski P, Mlynarski W, et al. Influence of genomic variation in FTO at 16q12.2, MC4R at 18q22 and NRXN3 at 14q31 genes on breast cancer risk. Mol Biol Rep. 2012;39:2915–9.
    Article CAS Google Scholar
  9. Lurie G, Gaudet MM, Spurdle AB, Carney ME, Wilkens LR, Yang HP, et al. The obesity-associated polymorphisms FTO rs9939609 and MC4R rs17782313 and endometrial cancer risk in non-Hispanic White women. PLoS One. 2011;6:e16756.
    Article CAS Google Scholar
  10. Delahanty RJ, Beeghly-Fadiel A, Xiang YB, Long J, Cai Q, Wen W, et al. Association of obesity-related genetic variants with endometrial cancer risk: a report from the Shanghai Endometrial Cancer Genetics Study. Am J Epidemiol. 2011;174:1115–26.
    Article Google Scholar
  11. Gaudet MM, Yang HP, Bosquet JG, Healey CS, Ahmed S, Dunning AM, et al. No association between FTO or HHEX and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev. 2010;19:2106–9.
    Article CAS Google Scholar
  12. Tang H, Dong X, Hassan M, Abbruzzese JL, Li D. Body mass index and obesity- and diabetes-associated genotypes and risk for pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2011;20:779–92.
    Article CAS Google Scholar
  13. Pierce BL, Austin MA, Ahsan H. Association study of type 2 diabetes genetic susceptibility variants and risk of pancreatic cancer: an analysis of PanScan-I data. Cancer Causes Control. 2011;22:877–83.
    Article Google Scholar
  14. Meyer TE, Boerwinkle E, Morrison AC, Volcik KA, Sanderson M, Coker AL, et al. Diabetes genes and prostate cancer in the atherosclerosis risk in communities study. Cancer Epidemiol Biomarkers Prev. 2010;19:558–65.
    Article CAS Google Scholar
  15. Lewis SJ, Murad A, Chen L. Davey Smith G, Donovan J, Palmer T, et al. Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk. PLoS One. 2010;5:e13485.
    Article Google Scholar
  16. Tarabra E, Actis GC, Fadda M, De Paolis P, Comandone A, Coda R, et al. The obesity gene and colorectal cancer risk: a population study in Northern Italy. Eur J Intern Med. 2012;23:65–9.
    Article CAS Google Scholar
  17. Brennan P, McKay J, Moore L, Zaridze D, Mukeria A, Szeszenia-Dabrowska N, et al. Obesity and cancer: Mendelian randomization approach utilizing the FTO genotype. Int J Epidemiol. 2009;38:971–5.
    Article Google Scholar
  18. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
    Article CAS Google Scholar
  19. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.
    CAS PubMed Google Scholar
  20. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.
    Article CAS Google Scholar
  21. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–34.
    Article CAS Google Scholar
  22. Nock NL, Plummer SJ, Thompson CL, Casey G, Li L. FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans. Carcinogenesis. 2011;32:748–56.
    Article CAS Google Scholar
  23. Fischer J, Koch L, Emmerling C, Vierkotten J, Peters T, Brüning JC, et al. Inactivation of the FTO gene protects from obesity. Nature. 2009;458:894–8.
    Article CAS Google Scholar
  24. Zimmermann E, Kring SI, Berentzen TL, Holst C, Pers TH, Hansen T, et al. Fatness-associated FTO gene variant increases mortality independent of fatness—in cohorts of Danish men. PLoS One. 2009;4:e4428.
    Article Google Scholar
  25. Stratigopoulos G, Padilla SL, LeDuc CA, Watson E, Hattersley AT, McCarthy MI, et al. Regulation of Fto/Ftm gene expression in mice and humans. Am J Physiol Regul Integr Comp Physiol. 2008;294:R1185–96.
    Article CAS Google Scholar
  26. Jowett JB, Curran JE, Johnson MP, Carless MA, Göring HH, Dyer TD, et al. Genetic variation at the FTO locus influences RBL2 gene expression. Diabetes. 2010;59:726–32.
    Article CAS Google Scholar

Download references